1. Home
  2. SEZL vs HAE Comparison

SEZL vs HAE Comparison

Compare SEZL & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sezzle Inc.

SEZL

Sezzle Inc.

HOLD

Current Price

$118.15

Market Cap

5.3B

Sector

Finance

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$103.09

Market Cap

4.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEZL
HAE
Founded
2016
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Financial Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
4.8B
IPO Year
2023
1996

Fundamental Metrics

Financial Performance
Metric
SEZL
HAE
Price
$118.15
$103.09
Analyst Decision
Buy
Buy
Analyst Count
6
9
Target Price
$109.33
$84.13
AVG Volume (30 Days)
769.9K
781.3K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.64
0.72
Revenue
$450,279,000.00
$910,373,000.00
Revenue This Year
$30.30
N/A
Revenue Next Year
$24.79
$5.23
P/E Ratio
$43.38
$141.60
Revenue Growth
66.08
N/A
52 Week Low
$49.50
$47.32
52 Week High
$195.71
$109.57

Technical Indicators

Market Signals
Indicator
SEZL
HAE
Relative Strength Index (RSI) 36.77 64.70
Support Level $108.51 $79.52
Resistance Level $136.59 $109.57
Average True Range (ATR) 5.08 2.51
MACD 0.28 -0.74
Stochastic Oscillator 8.44 65.43

Price Performance

Historical Comparison
SEZL
HAE

About SEZL Sezzle Inc.

Sezzle Inc is a financing institution that offers technology-driven payment platform. The Sezzle Platform offers a payments solution for consumers in the United States and Canada that has the ability to instantly extend credit at the point-of-sale, allowing consumers to purchase and receive merchandise while paying in installments over time. Consumers pay a portion of the purchase price at the point-of-sale as a down payment, and then pay off the remaining amount over time through scheduled payments. It also offer the ability to pay-in-full using the Sezzle Platform. Its operations comprise one reportable segment, the majority of which derives revenue from payment processing platform in North America.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.

Share on Social Networks: